Download Thymic Protein A - Complementary Prescriptions

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Immune system wikipedia , lookup

Monoclonal antibody wikipedia , lookup

Adaptive immune system wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Drosophila melanogaster wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

DNA vaccination wikipedia , lookup

Immunomics wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Innate immune system wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Molecular mimicry wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Thymus wikipedia , lookup

Transcript
Thymic Protein A
c
DESCRIPTION
PRECAUTIONS
Researchers have discovered a sobering fact: abnormal cells, such as cancer or tumor cells, are present in everyone's body—even those individuals
who exhibit no signs of disease. Despite this fact, only one in 25 people are
diagnosed with cancer. Scientists have begun to understand why the remaining 24 individuals do not succumb to carcinogenesis. These healthy individuals have developed a strong immune response known as cell-mediated
immunity, the body's defense against foreign invaders in the body. Research
has indicated that individuals with the longest life spans have enhanced cellmediated immunity.
Thymic Protein A is contraindicated when large doses of steroidal hormones
are administered, such as during prostate cancer treatments. Excessive
steroid levels interfere with the protein's ability to adhere to lymphocytes.
However, Thymic Protein A is effective in postmenopausal women undergoing hormone replacement therapy.
Cell-Mediated Immunity
The agents responsible for cell-mediated immunity are white blood cells
called T-lymphocytes (T-cells). There are two types of T-cells: T-4 lymphocytes and T-8 lymphocytes. The T-4 cells locate invaders such as tumor cells,
viruses, bacteria and parasites, then direct the T-8 cells to the location, where
the abnormality is destroyed. T-4 cells cannot do their job properly, however,
unless proteins from the thymus gland teach them how to perform effectively.
Despite this integral immune function, however, the thymus begins to shrink
after puberty. In most adults over 40, the thymus has shriveled to near nothing, leaving the body vulnerable to degenerative diseases.
The active ingredient in Proboost Thymic Protein A is the precise thymus protein known to program the T-4 lymphocytes, thereby enhancing cell-mediated
immunity. Immunologist Terry Beardsley, Ph.D., who discovered Thymic
Protein A 23 years ago, is the first scientist to produce the protein in an intact
manner in the laboratory through the use of cultured human thymus epithelial
cells. Thymic Protein A contains all 500 amino acids that comprise the thymic
protein molecules already in existence in the body. Other thymus products
contain only fragments (Thymopoetin contains only 5 amino acids, Thymosin
only 13). Because Thymic Protein A is unfragmented it fits into the T-4 cell
receptor site, triggering enhanced activity of the body's most powerful immune
defense.
Immune Stimulant
Research in both animals and humans has demonstrated that Thymic Protein
A has an astounding ability to enhance the immune system. Animals lacking
a thymus gland, when exposed to a non-sterile environment, normally contract a variety of infections. Conversely, mice receiving human thymus epithelial cells (from which Thymic Protein A is derived), develop no infections even
when living outside a sterile environment. In another study, Thymic Protein A
enhanced immune response and suppressed the disease of 22 cats infected
with the Feline Immunodeficiency Virus (FIV), the equivalent of AIDS. In addition, SmithKline Beecham's animal health research division discovered that a
minute amount of Thymic Protein A added to the rabies vaccination of dogs
doubles the potency and immune protection of the vaccine.
In humans, Thymic Protein A has demonstrated impressive results against a
host of conditions. In a recent pilot study, six individuals with Epstein-Barr
virus (EBV) and chronically elevated EBV antibodies were treated with 12
micrograms of Thymic Protein A daily for 60 days. The treatment produced a
50% or greater reduction in the level of Early Antigen Epstein-Barr viral loads
in the majority of individuals tested. Subjects also reported increased energy.
These results suggest that Thymic Protein A may be effective in the treatment
of mononucleosis and chronic fatigue syndrome, two conditions associated
with EBV.
The U.S. National Institute of Health (NIH) Division of AIDS has conducted its
own trials. In these studies, Thymic Protein A has suppressed HIV and live
HIV-infected blood cells. The researchers concluded that Thymic Protein A is
an immune stimulant.
RECOMMENDED DOSAGE
One to three packets per day, taken sublingually. Individuals seeking to
improve immune function can take one packet daily. Those with severe health
problems may require three packets per day until their immune system is
restored, at which time the dosage can be reduced. Individuals with HIV or
hepatitis B or C should take three doses per day until blood tests have been
normal for three to six months, then reduce to one dose per day. Because the
product is purified, there have been no allergic reactions reported to Thymic
Protein A, as is sometimes the case with whole thymus extracts.
PRODUCT CODE
#9122
30 pack (4 mcg)
FORMULA
Supplement Facts
Serving Size: 1 Packet
Amount Per Serving
Thymic Protein A
% Daily Value
4 mcg.
*
Other Ingredients: Maltodextrin
*Daily Value not established
REFERENCES
1. Hays EF, Beardsley TR. Immunologic effects of human thymic stromal
grafts and cell lines. Clin Immunol Immunopathol. 1984; 33(3):381-90.
2. Beardsley TR, Pierschbacher M, Wetzel GD, Hays EF. Induction of
T-cell maturation by a cloned line of thymic epithelium (TEPI). Proc
Natl Acad Sci USA. 1983; 80(19):6005-9.
3. Lapcevic J. A new biologically active thymic protein to stimulate
cell-mediated immunity. Townsend Newsletter for Doctors and Patients.
1997; Feb-Mar:70-2.
4. Hale P. The FIV connection. Searchlight. 1996; Summer:21-3.
5. Riordan N, et al. Pilot study of the effects of thymus protein on elevated
Epstein-Barr virus titers. Townsend Newsletter for Doctors and Patients.
1998; Feb-Mar:78-9.
Additional Benefits
Abundant anecdotal evidence also exists. There have been numerous reports
of chemotherapy patients who have maintained their total white blood count
at acceptable levels while treated with Thymic Protein A. Furthermore, physicians have used this nutrient to successfully treat patients suffering from
colds, flu, herpes shingles, sinusitis and hepatitis. Researchers are currently
conducting trials to investigate its role in cancer therapy. Thymic Protein A is
an exciting new anti-aging development. In the words of Dr. Julian Whitaker,
Thymic Protein A is "..likely the most powerful natural stimulant of the immune
system ever discovered."
CP ver. 082203
Information contained in this Product Technical Sheet is for educational purposes only and is not intended to provide personal medical advice.
Such advice should be obtained from a medical professional. Reproduction of any part of this work is prohibited.
® 2003 Complementary Prescriptions™, a division of Vitamin Research Products, Inc.